Skip to content

Attitudes of patients to their seizure medication and a possible withdrawal - EPAMA study

Attitudes of patients to their seizure medication and a possible withdrawal - EPAMA study - EPAMA

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00030094
Enrollment
300
Registered
2022-09-19
Start date
2022-10-18
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G40.8

Interventions

Group 1: Patients with epilepsy from the epilepsy outpatient clinics at the Charite who have been seizure-free for 2 years are interviewed with various questionnaires. These include: • Quality of lif

Sponsors

Klinik für Neurologie mit experimenteller Neurologie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: We will include: - Patients with confirmed epilepsy - Age = 18 years - Seizure freedom for 2 years prior to enrollment

Exclusion criteria

Exclusion criteria: We will exclude: - Patients who are not able to consent - Patients without sufficient knowledge of German

Design outcomes

Primary

MeasureTime frame
We will ask all patients of the epilepsy outpatient clinic at the Charite who have been seizure-free for 2 years from October 1, 2022 to October 1, 2023 to if they want to participate in our study. We will ask for reasons whether antiseizure medication would like to be withdrawn. In addition, we ask about general quality of life, depression, personality type, and anxiety.

Secondary

MeasureTime frame
We have no secondary outcomes.

Countries

Germany

Contacts

Public ContactMaria Ilyas-Feldmann

Klinik für NeurologieCharité – Universitätsmedizin BerlinCampus Mitte

maria.feldmann@charite.de030450560053

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026